Holiday Inn London - Kensington High St., an IHG Hotel, Wrights Lane, London, England, W8 5SP, United Kingdom
The 4th TPD Summit Europe returns as the foremost gathering for Targeted Protein Degradation professionals in Europe and globally. Scheduled from Tue, 19 Mar 2024, at 08:00 to Thu, 21 Mar 2024, at 17:30, the summit explores novel degrader development, E3 ligase/ligand discovery, and overcoming safety concerns in PROTACs. With 35+ experts, it covers degrader drug development, from hit finding to clinical candidate assessment, fostering connections among 110+ professionals for revolutionary advancements benefiting patients worldwide.
Join the pivotal 4th Operationalize Expanded Access Programs Summit in Boston from March 19th to March 21st, 2024, addressing the burgeoning interest in patient access to investigational medicines. This unique industry forum unites over 120 experts shaping Expanded Access Programs (EAPs), providing invaluable insights into global regulations, constructing reliable systems, and leveraging real-world data. Network with managed access teams from top pharmaceutical companies like Novartis, GSK, AstraZeneca, and more to explore innovative strategies, optimize EAP operationalization, and efficiently deliver life-saving treatments to patients. Don't miss this opportunity to join passionate EAP and clinical supply experts, physicians, and patients in revolutionizing access to vital therapies.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our